| Actively personalized vaccination trial for newly diagnosed glioblastoma N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ... Nature 565 (7738), 240-245, 2019 | 881 | 2019 |
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 841 | 2015 |
| TGF-β receptor inhibitors target the CD44high/Id1high glioma-initiating cell population in human glioblastoma J Anido, A Sáez-Borderías, A Gonzàlez-Juncà, L Rodón, G Folch, ... Cancer cell 18 (6), 655-668, 2010 | 716 | 2010 |
| LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy M Pascual-García, E Bonfill-Teixidor, E Planas-Rigol, C Rubio-Perez, ... Nature communications 10 (1), 2416, 2019 | 218 | 2019 |
| Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid F Martínez-Ricarte, R Mayor, E Martínez-Sáez, C Rubio-Pérez, E Pineda, ... Clinical Cancer Research 24 (12), 2812-2819, 2018 | 194 | 2018 |
| Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas S Bobillo, M Crespo, L Escudero, R Mayor, P Raheja, C Carpio, ... Haematologica 106 (2), 513, 2020 | 130 | 2020 |
| Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma L Escudero, A Llort, A Arias, A Diaz-Navarro, F Martínez-Ricarte, ... Nature communications 11 (1), 5376, 2020 | 113 | 2020 |
| Decompressive craniectomy in traumatic brain injury after the DECRA trial. Where do we stand? J Sahuquillo, F Martinez-Ricarte, MA Poca Current opinion in critical care 19 (2), 101-106, 2013 | 90 | 2013 |
| Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma B Shraibman, E Barnea, DM Kadosh, Y Haimovich, G Slobodin, I Rosner, ... Molecular & Cellular Proteomics 18 (6), 1255-1268, 2019 | 86 | 2019 |
| Infrared pupillometry. Basic principles and their application in the non-invasive monitoring of neurocritical patients F Martínez-Ricarte, A Castro, MA Poca, J Sahuquillo, L Expósito, ... Neurología (English Edition) 28 (1), 41-51, 2013 | 79 | 2013 |
| Epileptic features and survival in glioblastomas presenting with seizures M Toledo, S Sarria-Estrada, M Quintana, X Maldonado, ... Epilepsy research 130, 1-6, 2017 | 75 | 2017 |
| Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment C Rubio-Perez, E Planas-Rigol, JL Trincado, E Bonfill-Teixidor, A Arias, ... Nature communications 12 (1), 1503, 2021 | 69 | 2021 |
| Prognostic implications of epilepsy in glioblastomas M Toledo, S Sarria-Estrada, M Quintana, X Maldonado, ... Clinical neurology and neurosurgery 139, 166-171, 2015 | 61 | 2015 |
| Idiopathic normal pressure hydrocephalus: results of a prospective cohort of 236 shunted patients MA Poca, E Solana, FR Martínez-Ricarte, M Romero, D Gándara, ... Intracranial Pressure and Brain Monitoring XIV, 247-253, 2012 | 50 | 2012 |
| Intra-abdominal pressure: the neglected variable in selecting the ventriculoperitoneal shunt for treating hydrocephalus J Sahuquillo, F Arikan, MA Poca, M Noguer, F Martinez-Ricarte Neurosurgery 62 (1), 143-150, 2008 | 49 | 2008 |
| ctDNA-based liquid biopsy of cerebrospinal fluid in brain cancer L Escudero, F Martínez-Ricarte, J Seoane Cancers 13 (9), 1989, 2021 | 47 | 2021 |
| peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas E Martínez‐Sáez, V Peg, A Ortega‐Aznar, F Martínez‐Ricarte, J Camacho, ... Cancer medicine 5 (9), 2501-2512, 2016 | 37 | 2016 |
| A novel EGFRvIII T-cell bispecific antibody for the treatment of glioblastoma R Iurlaro, I Waldhauer, E Planas-Rigol, E Bonfill-Teixidor, A Arias, ... Molecular Cancer Therapeutics 21 (10), 1499-1509, 2022 | 25 | 2022 |
| Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition I Jiménez, J Carabia, S Bobillo, C Palacio, P Abrisqueta, C Pagès, ... Journal of Neuro-oncology 149, 13-25, 2020 | 23 | 2020 |
| GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma. W Wick, PY Dietrich, S Kuttruff, N Hilf, K Frenzel, A Admon, ... Journal of Clinical Oncology 36 (15_suppl), 2000-2000, 2018 | 23 | 2018 |
